Skip to main content
ZheJiang Tailin Bioengineering Co.,Ltd logo

ZheJiang Tailin Bioengineering Co.,Ltd — Investor Relations & Filings

Ticker · 300813 ISIN · CNE100003S89 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,000 across all filing types
Latest filing 2022-04-18 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300813

About ZheJiang Tailin Bioengineering Co.,Ltd

https://www.tailingood.com

ZheJiang Tailin Bioengineering Co.,Ltd. specializes in the research, development, and manufacturing of high-tech equipment for life sciences and pharmaceutical engineering. The company provides integrated solutions for microbial control, sterility testing, and aseptic processing. Its core product portfolio includes sterility test canisters and pumps, microbial limit testing systems, and hydrogen peroxide vapor (VHP) decontamination units. Tailin also develops advanced isolator technology for containment and aseptic applications, alongside analytical instruments such as Total Organic Carbon (TOC) analyzers and filter integrity testers. These products are designed to meet international regulatory standards, including GMP, USP, and EP. The company serves sectors such as biopharmaceuticals, medical devices, and laboratory research, focusing on product safety and quality through specialized engineering and microbial detection technologies.

Recent filings

Filing Released Lang Actions
2021年度董事会工作报告
Board/Management Information Classification · 95% confidence The document is titled '2021 年度董事会工作报告' which translates to '2021 Annual Board of Directors Work Report'. It details the board's activities, meetings, resolutions, committee work, and governance practices for the year 2021. It includes financial performance summaries but is primarily focused on the board's work and governance rather than full financial statements or audit opinions. The content aligns with a Board/Management Information report, as it discusses board meetings, resolutions, committee activities, and governance improvements. It is not an Annual Report (10-K) or Audit Report (AR) because it lacks comprehensive financial statements and audit opinions. It is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA) because it contains substantive content rather than just an announcement. Therefore, the appropriate classification is Board/Management Information (MANG).
2022-04-18 Chinese
关于变更注册资本并修订公司章程的公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement from Zhejiang Tailin Biotechnology Co., Ltd. regarding changes to the company's registered capital and amendments to the company's articles of association (公司章程). It includes detailed descriptions of the changes in share capital, dividend distribution plans, and extensive revisions to the company's bylaws, including governance structures, shareholder rights, board responsibilities, and independent director duties. The document is not a financial report, earnings release, or audit report, but rather a formal corporate governance and regulatory disclosure about capital changes and corporate charter amendments. It is a regulatory announcement about corporate governance and capital structure changes, not a full annual or interim report. Therefore, the most appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement that does not fit into more specific categories like Annual Report or Capital/Financing Update.
2022-04-18 Chinese
关于公司向全资子公司增资的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's decision to increase capital investment in its wholly-owned subsidiary. It details the board meeting resolution, the amount of capital increase, the subsidiary's financial data, and the purpose and risks of the investment. There are no financial statements or comprehensive financial reports presented, nor is this a report of financial results or an audit. The document is a formal announcement about a capital increase transaction, which fits the category of Capital/Financing Update (CAP). The document length is short and it is not merely announcing the publication of a report, so it is not a Report Publication Announcement (RPA).
2022-04-18 Chinese
监事会决议公告
Regulatory Filings Classification · 95% confidence The document is an announcement of the resolutions passed at the fifth meeting of the third Supervisory Board of Zhejiang Tailin Biotechnology Co., Ltd. It includes approvals of various reports such as the 2021 Annual Report, Supervisory Board Work Report, Profit Distribution Proposal, Financial Statements, Audit Report, Internal Control Self-Evaluation Report, and other related proposals. However, the document itself does not contain the full reports or detailed financial data but rather summarizes the meeting decisions and refers readers to the full reports published on the official disclosure website (http://www.cninfo.com.cn). The document is about the supervisory board meeting resolutions and approvals, not the full annual report or audit report itself. Given the nature of the content, it fits best under Regulatory Filings (RNS) as it is a regulatory announcement of meeting resolutions and approvals, not the actual reports or financial statements.
2022-04-18 Chinese
董事会议事规则
Governance Information Classification · 100% confidence The document is titled "董事会议事规则" which translates to "Board Meeting Rules" or "Rules of Procedure for the Board of Directors". It details the structure, responsibilities, meeting procedures, decision-making processes, and duties of the board of directors of the company 浙江泰林生物技术股份有限公司. The content focuses on governance practices, board composition, meeting protocols, and decision authority, which are typical elements of governance documentation. There is no financial data, audit information, or report publication mentioned. The document is not an announcement or a report of financial results or voting outcomes. It is a detailed governance document outlining internal rules and board procedures. Therefore, the most appropriate classification is Governance Information (CGR).
2022-04-18 Chinese
2021年年度审计报告
Audit Report / Information Classification · 100% confidence The document contains an audit report including an auditor's opinion, basis for the opinion, key audit matters, and detailed financial statements such as consolidated and parent company balance sheets, income statements, and cash flow statements for the fiscal year ending December 31, 2021. The presence of an auditor's report with audit opinion and detailed financial statements indicates this is a standalone audit report rather than a full annual report or other filing. The document length is substantial (15,000 characters) and contains actual financial data and audit details, not just an announcement or certification. Therefore, the document fits the definition of an Audit Report / Information (AR). FY 2021
2022-04-18 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.